Skip to main content

Healthcare Realty Reports Third Quarter 2025 Results

NASHVILLE, Tenn., Oct. 30, 2025 (GLOBE NEWSWIRE) — Healthcare Realty Trust Incorporated (NYSE:HR) today announced results for the third quarter ended September 30, 2025. THIRD QUARTER 2025 HIGHLIGHTSGAAP Net Loss of $(0.17) per share, NAREIT FFO of $0.34 per share, Normalized FFO of $0.41 per share, and FAD of $116.9 million (payout ratio of 73%) Same store cash NOI growth of +5.4% was driven by 90 basis points of occupancy increase and tenant retention of 88.6% with +3.9% cash leasing spreads Increased 2025 guidance for Normalized FFO per share to $1.59 – $1.61 and same store cash NOI growth to 4.00% – 4.75% Third quarter lease executions totaled 1.6 million square feet including 441,000 square feet of new lease executions During the third quarter and through October, completed asset sales of $404 million through...

Continue reading

CubeSmart Reports Third Quarter 2025 Results

MALVERN, Pa., Oct. 30, 2025 (GLOBE NEWSWIRE) — CubeSmart (NYSE: CUBE) today announced its operating results for the three and nine months ended September 30, 2025. “Overall, third quarter results were in line with our expectations. Our coastal and more urban markets maintained their strong performance while our sunbelt properties continued to experience tradeoffs between rate and occupancy,” commented President and Chief Executive Officer Christopher P. Marr. “We are encouraged as operating trends continue to stabilize and are confident that our systems position us well to maximize long-term revenue within our highest-quality portfolio.” Key Highlights for the Third QuarterReported diluted earnings per share (“EPS”) attributable to the Company’s common shareholders of $0.36. Reported funds from operations (“FFO”), as adjusted,...

Continue reading

Plus Therapeutics Reports Third Quarter Financial Results and Recent Business Highlights

US market introduction of the CNSide® CSF diagnostics platform, with first national coverage agreement with UnitedHealthcare Presented positive RESPECT-LM Ph1 clinical trial results HOUSTON, Oct. 30, 2025 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, today announces financial results for the third quarter ended September 30, 2025 and provides an overview of recent and upcoming business highlights. “Our team continues to execute solidly across the three most important business verticals: diagnostics, therapeutics, and capital structure,” said Marc H. Hedrick, M.D., Plus Therapeutics President and Chief Executive Officer. “In the fourth quarter,...

Continue reading

Westwood Holdings Group, Inc. Reports Third Quarter 2025 Results

MDST ETF Surpasses $150 million and Captured 30% of September Monthly Midstream ETF FlowsWEBs Partnership Launches Eleven New Sector ETFsPrivate Fund Raising Exceeds Expectations DALLAS, Oct. 30, 2025 (GLOBE NEWSWIRE) — Westwood Holdings Group, Inc. (NYSE: WHG) today reported third quarter 2025 earnings. Significant items included:Investment strategies beating their primary benchmarks included Income Opportunity, Multi-Asset Income, Alternative Income, Credit Opportunities, Real Estate Income and Tactical Growth. Income Opportunity and Multi-Asset Income each posted top quartile rankings vs. peers and Real Estate Income posted a top decile ranking. Quarterly revenues totaled $24.3 million vs. $23.1 million in the second quarter and $23.7 million a year ago. Income of $3.7 million compared with $1.0 million in the second quarter...

Continue reading

Artesian Resources Corporation Reports Third Quarter and Year-To-Date 2025 Results

NEWARK, Del., Oct. 30, 2025 (GLOBE NEWSWIRE) — Artesian Resources Corporation (Nasdaq: ARTNA), a leading provider on the Delmarva Peninsula of water and wastewater services, and a number of other related business services, today announced third quarter and year-to-date results for 2025.  Diluted net income per share increased to $0.68 in the third quarter and $1.81 year-to-date Net income increased $0.1 million (2.2%) in the third quarter and $2.1 million (12.9%) year-to-date Invested $40.5 million year-to-date in water and wastewater infrastructureThird Quarter Results Net income for the three months ended September 30, 2025 was $7.0 million, a $0.1 million, or 2.2%, increase compared to net income for the three months ended September 30, 2024. Diluted net income per share increased 3.0% to $0.68, compared to $0.66 for the...

Continue reading

SAMFINE CREATION HOLDINGS GROUP LIMITED Announces First Half 2025 Unaudited Financial Results

HONG KONG, Oct. 30, 2025 (GLOBE NEWSWIRE) — SAMFINE CREATION HOLDINGS GROUP LIMITED (Nasdaq: SFHG) (the “Company” or “Samfine”), a printing service provider headquartered in Hong Kong, today announced its unaudited financial results for the six months ended June 30, 2025. Overview:Revenue was HK$82.1 million (US$10.5 million) for the six months ended June 30, 2025, representing an increase of 0.2% from HK$81.9 million for the same period in 2024. Net loss was HK$8.5 million (US$1.1 million) for the six months ended June 30, 2025, as compared with a net income of HK$0.8 million for the same period in 2024.Six Months Ended June 30, 2025 Financial Results Revenue. Revenue remained relatively stable at HK$82,121,233 (US$10,461,437) for the six months ended June 30, 2025, representing a marginal increase of 0.2% compared to HK$81,934,259...

Continue reading

SPS Commerce Reports Third Quarter 2025 Financial Results

Company delivers 99th consecutive quarter of topline growthThird quarter 2025 revenue grew 16% and recurring revenue grew 18% from the third quarter of 2024Appoints new Chief Commercial Officer as longtime Chief Revenue Officer intends to retireAnnounces new Share Repurchase Program MINNEAPOLIS, Oct. 30, 2025 (GLOBE NEWSWIRE) — SPS Commerce, Inc. (NASDAQ: SPSC), a leader in retail supply chain cloud services, today announced financial results for the third quarter ended September 30, 2025. Financial Highlights Third Quarter 2025 Financial HighlightsRevenue was $189.9 million in the third quarter of 2025, compared to $163.7 million in the third quarter of 2024, reflecting 16% growth. Recurring revenue grew 18% from the third quarter of 2024. Net income was $25.6 million or $0.67 per diluted share, compared to net income of $23.5...

Continue reading

JAKKS Pacific Reports Third Quarter 2025 Financial Results

Board approves Quarterly Cash Dividend SANTA MONICA, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) — JAKKS Pacific, Inc. (NASDAQ: JAKK) today reported financial results for the third quarter ended September 30, 2025. Third Quarter 2025Net sales were $211.2 million, a year-over-year decrease of $110.4 million or 34%, driven largely by a reduction in direct-import sales due to a combination of customers anticipating lower consumer demand in response to tariff-driven price increases and the lack of new theatrical release-related product vs. prior yearUS net sales were $154.5 million, down 40% compared to Q3 2024 Rest of World net sales were $56.7 million, down 15% compared to Q3 2024Gross margin of 32.0% vs. 33.8% in Q3 2024, driven by US tariffs and higher royalty expense Gross profit of $67.6 million, down $41.2 million compared...

Continue reading

Stryker reports third quarter 2025 operating results

Portage, Michigan, Oct. 30, 2025 (GLOBE NEWSWIRE) — Stryker (NYSE:SYK) reported operating results for the third quarter of 2025: Third Quarter ResultsReported net sales increased 10.3% to $6.1 billion Organic net sales increased 9.5% Reported operating income margin of 18.7% Adjusted operating income margin(1) increased 90 bps to 25.6% Reported EPS increased 2.8% to $2.22 Adjusted EPS(1) increased 11.1% to $3.19  Third Quarter Net Sales Growth Overview  Reported   Foreign Currency Exchange   Constant Currency   Acquisitions / Divestitures   OrganicMedSurg and Neurotechnology         14.4         %           0.5         %           13.9         %           5.5         %           8.4         %Orthopaedics         3.9                     0.8                     3.1                     (8.3)            11.4          Total         10.3         %           0.7         %           9.6         %           0.1         %           9.5         %“We...

Continue reading

GSI Technology, Inc. Announces Second Quarter Fiscal 2026 Results

Closed $50 Million Financing to Fund Gemini-II Platform Completion and Commence Plato Chip Design SUNNYVALE, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) — GSI Technology, Inc. (Nasdaq: GSIT) today reported financial results for its second fiscal quarter ended September 30, 2025. Summary Comments for Second Quarter Fiscal Year 2026Revenue increased 3% sequentially and 42% year-over-year, fueled by strong market momentum for leading SRAM solutions; Quarter-end cash balance of $25.3 million, up from $13.4 million at the end of Q4 FY2025, including proceeds from the “at-the-market” (ATM) program; Subsequent to quarter-end, closed a registered direct offering for gross proceeds of $50 million; The Space Development Agency awarded an additional $752,000 under our existing SBIR to characterize our current Gemini-II die for radiation tolerance;...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.